| 000 | 01445 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518000805.0 | ||
| 264 | 0 | _c20200414 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1536-3678 | ||
| 024 | 7 |
_a10.1097/MPH.0000000000001314 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSedky, Mohamed S | |
| 245 | 0 | 0 |
_aOutcome of High-risk Langerhans Cell Histiocytosis (LCH) in Egyptian Children, Does Intermediate-dose Methotrexate Improve the Outcome? _h[electronic resource] |
| 260 |
_bJournal of pediatric hematology/oncology _c11 2019 |
||
| 300 |
_a635-643 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEgypt _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHistiocytosis, Langerhans-Cell _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aProhibitins |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aHamouda, Asmaa | |
| 700 | 1 | _aTaha, Hala | |
| 700 | 1 | _aZaky, Iman | |
| 700 | 1 | _aHassanain, Omayma | |
| 700 | 1 | _aEl Hemaly, Ahmed | |
| 700 | 1 | _aElHaddad, Alaa | |
| 773 | 0 |
_tJournal of pediatric hematology/oncology _gvol. 41 _gno. 8 _gp. 635-643 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MPH.0000000000001314 _zAvailable from publisher's website |
| 999 |
_c28866791 _d28866791 |
||